Educational dose math only — not medical advice, not a product recommendation, and not a pass/fail on whether a supplement will work for you.
0 100% 150%+

—

Enter label dose

Trial reference

From your label

Per-day total — not per serving unless you take one serving

Enter your label dose — the gauge updates instantly.

1,800 mg twice per day (3,600 mg per day total) for 24 weeks in 62 adults with statin-intolerant dyslipidemia, randomized against placebo. LDL fell significantly. The effect is real because the active molecule is real: monacolin K is chemically identical to lovastatin, a statin-class drug effect delivered through a supplement label.

Educational only — not medical advice. Disclaimer.

NIH DSLD market slice

Median900 mg
Products554
Below100%

Bulk CSV dump 16 January 2026 · label entries through 2025. Disclosed amounts only — proprietary blends without gram weights excluded.

Trial floors

Primary

Statin-intolerant RCT (Becker 2009) · 3,600 mg over 24 weeks (limited evidence · how we grade this) · Benefit shown — 1,800 mg twice per day (3,600 mg per day total) for 24 weeks in 62 adults with statin-intolerant dyslipidemia, randomized against placebo. LDL fell significantly. The effect is real because the active molecule is real: monacolin K is chemically identical to lovastatin, a statin-class drug effect delivered through a supplement label.

Safety red flags

  • If you take any statin, or stopped one because of side effects: this needs a prescriber conversation before the bottle, because the combination duplicates a drug you already react to.
  • Muscle pain, new weakness, or dark urine while using red yeast rice: stop and contact a clinician promptly.

Label reading notes

  • Monacolin K in red yeast rice is chemically identical to lovastatin. The studied product worked like a statin; that is a pharmacological equivalence statement, and it is why the prescriber conversations below exist.
  • Monacolin content varies several-fold between batches and brands, so the rice milligrams on the label do not tell you the dose of the active molecule. Standardization, not the total weight, is the number that matters.
  • The FDA treats red yeast rice products containing therapeutic monacolin levels as an unapproved drug, not a supplement.
  • Contamination risk: citrinin, a nephrotoxin from the fermentation process, is a documented quality problem; third-party testing matters more than usual here.
  • Not a "natural alternative to statins." A statin-class compound with an unpredictable label, which is a different thing.